atorvastatin has been researched along with 2019 Novel Coronavirus Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 18 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bram, Y; Chen, S; Copertino, DC; Duarte, RRR; Han, Y; Iñiguez, LP; Marston, JL; Nixon, DF; Powell, TR; Schwartz, RE | 1 |
| Andrews, L; Goldin, L; Guy, J; Kleja, K; Korwek, K; Perlin, JB; Poland, RE; Sands, KE; Shen, Y | 1 |
| Abdelaaty, KM; Elhamaky, AS; Elsawy, NH; Eltahan, NH; Emara, MM | 1 |
| Davoodian, N; Elyasi, S; Hejazi, S; Mehrad-Majd, H; Mircheraghi, F; Salarbashi, D | 1 |
| Boardman, HF; Janjua, SS; Javaid, KM; Johansen, A; Sami, A; Toh, LS | 1 |
| Ansbro, É; Aoun Bahous, S; Boulle, P; Masri, S; Molfino, L; Perel, P; Prieto-Merino, D; Willis, R | 1 |
| Abedini, A; Abri, H; Aghakouchakzadeh, M; Aliannejad, R; Amin, A; Ansarin, K; Baghizadeh, E; Bakhshandeh, H; Barco, S; Beigmohammadi, MT; Bikdeli, B; Dabbagh, A; Eslami, V; Farrokhpour, M; Goldhaber, SZ; Gupta, A; Hadavand, N; Hajighasemi, A; Hosseini, SH; Jamalkhani, S; Jimenez, D; Kakavand, H; Kashefizadeh, A; Khalili, H; Kirtane, AJ; Klok, FA; Krumholz, HM; Lip, GYH; Lookzadeh, S; Madhavan, MV; Maleki, M; Matin, S; Moghadam, KG; Mohammadi, K; Mohebbi, B; Monreal, M; Mousavian, SM; Najafi, A; Parhizgar, SE; Parikh, SA; Payandemehr, P; Piazza, G; Rafiee, F; Rahmani, H; Rashidi, F; Rezaeifar, P; Rezaian, S; Riahi, T; Sadeghian, S; Sadeghipour, P; Sethi, SS; Sezavar, SH; Shafaghi, S; Sharif-Kashani, B; Siegerink, B; Soleimanzadeh, M; Spatz, ES; Stone, GW; Tabrizi, S; Tahamtan, O; Talakoob, H; Talasaz, AH; Tassell, BWV; Tojari, T; Yadollahzadeh, M; Zoghi, E | 1 |
| Carlson, KE; Frieman, M; Furlong, B; Goyal, G; Hammond, H; Horvath, V; Ingber, DE; Kaushal, S; Kosti, I; Le, BL; Logue, J; Marić, I; Novak, R; Oskotsky, TT; Powers, RK; Prabhala, P; Rodas, M; Sirota, M; Soong, M; Sperry, MM; Stevenson, DK; Takeda, T; Wong, RJ | 1 |
| Bugarín-González, R; Figueiras, A; González-Barcala, FJ; Herdeiro, MT; Piñeiro-Lamas, M; Pintos-Rodríguez, S; Salgado-Barreira, Á; Visos-Varela, I; Zapata-Cachafeiro, M | 1 |
| Chung, CW; Friedman, HJ; Rodriguez-Nava, G; Trelles-Garcia, DP; Trelles-Garcia, VP; Yanez-Bello, MA | 1 |
| Abedini, A; Amin, A; Bakhshandeh, H; Beigmohammadi, MT; Bikdeli, B; Dabbagh, A; Farrokhpour, M; Goldhaber, SZ; Gupta, A; Hadavand, N; Hajighasemi, A; Jamalkhani, S; Jimenez, D; Khalili, H; Kirtane, AJ; Krumholz, HM; Lip, GYH; Lookzadeh, S; Madhavan, MV; Maleki, M; Matin, S; Mohebbi, B; Monreal, M; Parhizgar, SE; Parikh, SA; Payandemehr, P; Piazza, G; Rashidi, F; Rezaeifar, P; Riahi, T; Sadeghian, S; Sadeghipour, P; Sezavar, H; Shahmirzaei, S; Sharif-Kashani, B; Tahamtan, O; Talasaz, AH; Yadollahzadeh, M | 1 |
| Bhati, S; Bhatnagar, S; Bhushan, S; Deepti, S; Dwivedi, T; Garg, R; Ghati, N; Guleria, R; Gupta, R; Mahendran, M; Mani, K; Mohan, A; Roy, A; Saxena, A; Thakur, A; Tiwari, P | 1 |
| Chen, Y; Fu, B; Li, P | 1 |
| Amini, H; Azhdari Tehrani, H; Haji Aghajani, M; Hatami, F; Moradi, O; Pourheidar, E; Rabiei, MM; Sistanizad, M | 1 |
| Bruckert, E; Gallo, A; Mourad, JJ; Orlowski, S | 1 |
| Ahmadi, F; Ahmadi, M; Davoudi, A; Hassantabar, R; Kasgari, HA; Najafi, N; Rabiee, M; Sharifi, A; Tayebi, A | 1 |
| Bhandari, S; Dadhwal, DS; Dogra, V; Gupta, S; Raina, S; Sharma, A; Sharma, C; Singh, B; Sood, V | 1 |
1 review(s) available for atorvastatin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Coronaviruses, cholesterol and statins: Involvement and application for Covid-19.
Topics: Animals; Antiviral Agents; Atorvastatin; Cholesterol; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Membrane Microdomains; SARS-CoV-2 | 2021 |
7 trial(s) available for atorvastatin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial.
Topics: Adolescent; Adult; Aged; Anticoagulants; Atorvastatin; COVID-19; Critical Care; Double-Blind Method; Extracorporeal Membrane Oxygenation; Female; Heparin; Humans; Intensive Care Units; Iran; Male; Middle Aged; Odds Ratio; SARS-CoV-2; Treatment Outcome; Venous Thromboembolism; Young Adult | 2022 |
Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial.
Topics: Atorvastatin; COVID-19; Health Personnel; Humans; Pandemics; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome | 2022 |
Atorvastatin Efficacy in the Management of Mild to Moderate Hospitalized COVID-19: A Pilot Randomized Triple-blind Placebo- controlled Clinical Trial.
Topics: Atorvastatin; C-Reactive Protein; COVID-19; Double-Blind Method; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Oxygen; Pilot Projects | 2022 |
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.
Topics: Adult; Atorvastatin; COVID-19; Double-Blind Method; Female; Humans; Intensive Care Units; Male; Middle Aged; Thrombosis; Treatment Outcome | 2023 |
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Topics: Anticoagulants; Atorvastatin; COVID-19; COVID-19 Drug Treatment; Critical Illness; Double-Blind Method; Enoxaparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iran; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Thrombosis; Time Factors; Treatment Outcome; Venous Thromboembolism | 2020 |
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Topics: Adult; Aged; Aspirin; Atorvastatin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Host-Pathogen Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; India; Male; Middle Aged; Pandemics; Platelet Aggregation Inhibitors; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Time Factors; Treatment Outcome | 2020 |
A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial.
Topics: Aspirin; Atorvastatin; COVID-19; Humans; India; Nicorandil; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Treatment Outcome | 2021 |
10 other study(ies) available for atorvastatin and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry.
Topics: Antiviral Agents; Atorvastatin; Cell Line; Coronavirus 3C Proteases; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Doxycycline; Drug Approval; Drug Repositioning; Gene Expression Regulation; Humans; Lung; Models, Biological; Molecular Docking Simulation; Organoids; Raloxifene Hydrochloride; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Trifluoperazine; United States; United States Food and Drug Administration; Vesiculovirus; Virus Internalization | 2021 |
Discontinuation of atorvastatin use in hospital is associated with increased risk of mortality in COVID-19 patients.
Topics: Atorvastatin; COVID-19; Hospital Mortality; Hospitals; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2022 |
Anti-osteoporosis medication dispensing by clinical commissioning groups in England - an ecological study of variability in practice and of the effect of the Covid-19 pandemic.
Topics: Aged; Atorvastatin; Bone Density Conservation Agents; COVID-19; England; Female; Hip Fractures; Humans; Male; Osteoporosis; Pandemics | 2023 |
Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: an implementation study.
Topics: Atorvastatin; Cardiovascular Diseases; Cholesterol; COVID-19; Drug Combinations; Humans; Lebanon; Pandemics | 2023 |
Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients.
Topics: Atorvastatin; Bayes Theorem; COVID-19; Drug Repositioning; Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Medical Records; SARS-CoV-2; Simvastatin | 2023 |
Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study.
Topics: Atorvastatin; Case-Control Studies; COVID-19; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Outpatients; Simvastatin | 2023 |
Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study.
Topics: Aged; Atorvastatin; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Treatment Outcome | 2020 |
2019 novel coronavirus disease with secondary ischemic stroke: two case reports.
Topics: Aspirin; Atorvastatin; Brain Ischemia; COVID-19; Fibrinolytic Agents; Humans; Ischemic Stroke; Male; Middle Aged; Pandemics; SARS-CoV-2; Tirofiban | 2021 |
Promising effects of atorvastatin on mortality and need for mechanical ventilation in patients with severe COVID-19; a retrospective cohort study.
Topics: Adult; Aged; Atorvastatin; COVID-19; Hospital Mortality; Humans; Middle Aged; Respiration, Artificial; Retrospective Studies; SARS-CoV-2 | 2021 |
Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning.
Topics: Aged; Algorithms; Atorvastatin; COVID-19; Drug Prescriptions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Iran; Machine Learning; Male; Middle Aged; Retrospective Studies; Rosuvastatin Calcium; Severity of Illness Index; Simvastatin | 2021 |